Free Trial

Telix Pharmaceuticals Limited American Depositary Shares (TLX) SEC Filings & 10K Form

Telix Pharmaceuticals Limited American Depositary Shares logo
$13.61 -2.54 (-15.73%)
Closing price 04:00 PM Eastern
Extended Trading
$13.62 +0.02 (+0.11%)
As of 04:38 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Telix Pharmaceuticals Limited American Depositary Shares SEC Filings

DateFilerForm TypeView
03/18/2025
3:28 PM
Telix Pharmaceuticals Ltd (Filer)
Telix Pharmaceuticals Limited American Depositary Shares (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/12/2025
7:13 AM
Telix Pharmaceuticals Ltd (Filer)
Telix Pharmaceuticals Limited American Depositary Shares (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/26/2025
6:34 AM
Telix Pharmaceuticals Ltd (Filer)
Telix Pharmaceuticals Limited American Depositary Shares (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/24/2025
3:53 PM
Telix Pharmaceuticals Ltd (Filer)
Telix Pharmaceuticals Limited American Depositary Shares (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/24/2025
6:01 AM
Telix Pharmaceuticals Ltd (Filer)
Telix Pharmaceuticals Limited American Depositary Shares (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
02/21/2025
6:07 AM
Telix Pharmaceuticals Ltd (Filer)
Telix Pharmaceuticals Limited American Depositary Shares (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/14/2025
6:00 AM
Kluge Andreas (Filed by)
Telix Pharmaceuticals Ltd (Subject)
Telix Pharmaceuticals Limited American Depositary Shares (Subject)
Form SCHEDULE 13G
02/14/2025
6:00 AM
Behrenbruch Christian (Filed by)
Telix Pharmaceuticals Ltd (Subject)
Telix Pharmaceuticals Limited American Depositary Shares (Subject)
Form SCHEDULE 13G
02/13/2025
7:09 AM
Telix Pharmaceuticals Ltd (Filer)
Telix Pharmaceuticals Limited American Depositary Shares (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/31/2025
6:19 AM
Telix Pharmaceuticals Ltd (Filer)
Telix Pharmaceuticals Limited American Depositary Shares (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/27/2025
3:40 PM
Telix Pharmaceuticals Ltd (Filer)
Telix Pharmaceuticals Limited American Depositary Shares (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/13/2025
5:49 AM
Telix Pharmaceuticals Ltd (Filer)
Telix Pharmaceuticals Limited American Depositary Shares (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/30/2024
3:05 PM
Telix Pharmaceuticals Ltd (Filer)
Telix Pharmaceuticals Limited American Depositary Shares (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/19/2024
5:16 AM
Telix Pharmaceuticals Ltd (Filer)
Telix Pharmaceuticals Limited American Depositary Shares (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
11/19/2024
6:30 AM
Telix Pharmaceuticals Ltd (Filer)
Telix Pharmaceuticals Limited American Depositary Shares (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/14/2024
6:00 AM
Telix Pharmaceuticals Ltd (Filer)
Telix Pharmaceuticals Limited American Depositary Shares (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/12/2024
11:15 PM
Telix Pharmaceuticals Ltd (Filer)
Telix Pharmaceuticals Limited American Depositary Shares (Filer)
Form EFFECT
11/12/2024
4:00 PM
Telix Pharmaceuticals Ltd (Filer)
Telix Pharmaceuticals Limited American Depositary Shares (Filer)
Form SEC STAFF ACTION
11/12/2024
12:33 PM
Telix Pharmaceuticals Ltd (Filer)
Telix Pharmaceuticals Limited American Depositary Shares (Filer)
Form CERT
10/29/2024
6:03 PM
Telix Pharmaceuticals Ltd (Filer)
Telix Pharmaceuticals Limited American Depositary Shares (Filer)
Form 20FR12B/A
10/17/2024
4:23 PM
JPMorgan Chase Bank, N.A. - ADR Depositary (Filed by)
Telix Pharmaceuticals Ltd (Subject)
Telix Pharmaceuticals Limited American Depositary Shares (Subject)
Form F-6
Registration statement under the Securities Act of 1933 for depositary shares evidenced by American depositary receipts  
10/17/2024
3:05 PM
Telix Pharmaceuticals Ltd (Filer)
Telix Pharmaceuticals Limited American Depositary Shares (Filer)
Form 20FR12B
06/14/2024
11:19 AM
Telix Pharmaceuticals Ltd (Filer)
Telix Pharmaceuticals Limited American Depositary Shares (Filer)
Form RW
06/14/2024
7:12 AM
Telix Pharmaceuticals Ltd (Filer)
Telix Pharmaceuticals Limited American Depositary Shares (Filer)
Form RW
06/05/2024
5:43 AM
Telix Pharmaceuticals Ltd (Filer)
Telix Pharmaceuticals Limited American Depositary Shares (Filer)
Form F-1/A
05/30/2024
5:31 AM
JPMorgan Chase Bank, N.A. - ADR Depositary (Filed by)
Telix Pharmaceuticals Ltd (Subject)
Telix Pharmaceuticals Limited American Depositary Shares (Subject)
Form F-6
Registration statement under the Securities Act of 1933 for depositary shares evidenced by American depositary receipts  
05/17/2024
5:24 AM
Telix Pharmaceuticals Ltd (Filer)
Telix Pharmaceuticals Limited American Depositary Shares (Filer)
Form F-1
Registration statement for securities of certain foreign private issuers  
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:TLX) was last updated on 4/4/2025 by MarketBeat.com Staff
From Our Partners